What is Profound Medical's D&A?

Profound Medical (PROF) reported D&A of $93K in Q1 2026.

How has Profound Medical's D&A changed year-over-year?

Profound Medical's D&A decreased by 19.8% year-over-year, from $116K to $93K.

What is the long-term trend for Profound Medical's D&A?

Over 2 years (2023 to 2025), Profound Medical's D&A has grown at a -28.4% compound annual growth rate (CAGR), from $727K to $373K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Profound Medical PROF D&A

D&A at other companies

TriSalus Life Sciences, Inc.TLSI

$135K-21.5%

BioventusBVS

$11.21M-5.6%

Globus MedicalGMED

$69.86M+6.4%

Segments

By geography

See full

US$66K-35.9%

CA$15K+15.4%

FI$12K—

Other financials

Income statement

See full

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

See full

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

See full

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

See full

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

See full

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

See full

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Profound Medical's D&A?: Profound Medical (PROF) reported D&A of $93K in Q1 2026.
How has Profound Medical's D&A changed year-over-year?: Profound Medical's D&A decreased by 19.8% year-over-year, from $116K to $93K.
What is the long-term trend for Profound Medical's D&A?: Over 2 years (2023 to 2025), Profound Medical's D&A has grown at a -28.4% compound annual growth rate (CAGR), from $727K to $373K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.